TuHURA Biosciences, Inc./NV — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-08-13 reports creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) as of 2026-08-07. The filing document references financial statements and exhibits but the specific counterparty, dollar amount, terms, and nature of the obligation are not disclosed in the provided text extract.
Why this rating
Cannot assess materiality without obligation details. If material relative to $111M market cap, significance rises sharply; if routine/small, it remains routine disclosure.
Extracted items
- 2.03 material obligation
- 9.01 exhibits
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.